Garcia-Romeu A - Search Results

1

Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations.

Ortiz CE, Dourron HM, Sweat NW, Garcia-Romeu A, MacCarthy S, Anderson BT, Hendricks PS. Ortiz CE, et al. Neuropharmacology. 2022 Aug 15;214:109127. doi: 10.1016/j.neuropharm.2022.109127. Epub 2022 May 13. Neuropharmacology. 2022. PMID: 35577136 Free article. Review.

2

Kratom withdrawal: Discussions and conclusions of a scientific expert forum.

Henningfield JE, Chawarski MC, Garcia-Romeu A, Grundmann O, Harun N, Hassan Z, McCurdy CR, McMahon LR, Sharma A, Shoaib M, Singh D, Smith KE, Swogger MT, Vicknasingam B, Walsh Z, Wang DW, Huestis MA. Henningfield JE, et al. Among authors: garcia romeu a. Drug Alcohol Depend Rep. 2023 Mar 15;7:100142. doi: 10.1016/j.dadr.2023.100142. eCollection 2023 Jun. Drug Alcohol Depend Rep. 2023. PMID: 37397437 Free PMC article. No abstract available.

3

Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.

Garcia-Romeu A, Griffiths RR, Johnson MW. Garcia-Romeu A, et al. Curr Drug Abuse Rev. 2014;7(3):157-64. doi: 10.2174/1874473708666150107121331. Curr Drug Abuse Rev. 2014. PMID: 25563443 Free PMC article. Clinical Trial.

4

Long-term follow-up of psilocybin-facilitated smoking cessation.

Johnson MW, Garcia-Romeu A, Griffiths RR. Johnson MW, et al. Am J Drug Alcohol Abuse. 2017 Jan;43(1):55-60. doi: 10.3109/00952990.2016.1170135. Epub 2016 Jul 21. Am J Drug Alcohol Abuse. 2017. PMID: 27441452 Free PMC article. Clinical Trial.

5

Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions.

Garcia-Romeu A, Richards WA. Garcia-Romeu A, et al. Int Rev Psychiatry. 2018 Aug;30(4):291-316. doi: 10.1080/09540261.2018.1486289. Epub 2018 Nov 13. Int Rev Psychiatry. 2018. PMID: 30422079 Review.

6

Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.

Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS. Yaden DB, et al. Int J Drug Policy. 2021 Dec;98:103380. doi: 10.1016/j.drugpo.2021.103380. Epub 2021 Jul 27. Int J Drug Policy. 2021. PMID: 34329952 Review.

7

IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.

Yaden DB, Berghella AP, Hendricks PS, Yaden ME, Levine M, Rohde JS, Nayak S, Johnson MW, Garcia-Romeu A. Yaden DB, et al. Among authors: garcia romeu a. Pharmacol Res. 2024 Jan;199:106998. doi: 10.1016/j.phrs.2023.106998. Epub 2023 Nov 28. Pharmacol Res. 2024. PMID: 38029805 Free article. Review.

8

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.

Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Johnson MW, et al. J Psychopharmacol. 2014 Nov;28(11):983-92. doi: 10.1177/0269881114548296. Epub 2014 Sep 11. J Psychopharmacol. 2014. PMID: 25213996 Free PMC article. Clinical Trial.

9

Clinical applications of hallucinogens: A review.

Garcia-Romeu A, Kersgaard B, Addy PH. Garcia-Romeu A, et al. Exp Clin Psychopharmacol. 2016 Aug;24(4):229-68. doi: 10.1037/pha0000084. Exp Clin Psychopharmacol. 2016. PMID: 27454674 Free PMC article. Review.

10

An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.

Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. Johnson MW, et al. J Psychopharmacol. 2017 Jul;31(7):841-850. doi: 10.1177/0269881116684335. Epub 2017 Jan 18. J Psychopharmacol. 2017. PMID: 28095732 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page